Chris Roberts
Based in New York City, Chris Roberts has been writing about cannabis since spending a few months in Humboldt County in 2009. His work has been published in SF Weekly, Cannabis Now, The Guardian, High Times, and San Francisco Magazine, among others.
Based in New York City, Chris Roberts has been writing about cannabis since spending a few months in Humboldt County in 2009. His work has been published in SF Weekly, Cannabis Now, The Guardian, High Times, and San Francisco Magazine, among others.
Most popular articles
Leafly Investigation: California Has a Dirty Cannabis Problem
Pesticides, molds, and other pathogens are turning up in medical cannabis across California. Rules are coming, but until then it's "buyer beware."
Chris Roberts - February 15, 2017Under Trump, Legal Cannabis Is a Deportable Offense
More and more, those who admit to having ever used cannabis are being refused entry into the United States—or deported if they’re already here.
Chris Roberts - March 27, 2017California’s New Edibles Limits Will Ban Popular Products
Restrictions on the amount of THC in cannabis-infused edibles kick in next year and will outlaw some of the state's most popular products.
Chris Roberts - November 27, 2017Crowdfunding Site Cancels Aid to California Wildfire Victims—Because Cannabis
Rejection by third-party payment processors is a familiar story in cannabis, but abruptly ending an aid effort during a dire emergency somehow feels different.
Chris Roberts - October 17, 2017The Great Cannabis Clash of Calaveras County
California’s Gold Country is dying. The marijuana industry has arrived, offering tax revenue and job opportunities. So why are locals rejecting it?
Chris Roberts - August 1, 2017Articles contributed to Leafly (by most recent)
Hemp cleans toxic soil and produces clean CBD flower, study finds
Researchers found that stressing hemp with toxic soil actually boosted CBD levels.
Chris Roberts - December 23, 2019Why did San Francisco’s cannabis store ‘cashless ATMs’ suddenly shut down?
Unsolved mystery: Over 48 hours, every one of the city's cannabis cash machines went dark. Nobody seems to know why.
Chris Roberts - November 15, 2019Putin, hackers, and cannabis: The bizarre story of an Israeli-American jailed in Russia
Cannabis, initially given as the sole reason for 26-year-old Naama Issachar's detention, appears to have been merely a convenient excuse.
Chris Roberts - October 23, 2019This is the first hemp strain to be awarded a US patent
Famous for the iconic Charlotte’s Web strain and fresh from a big IPO, Colorado’s Stanley brothers have secured the first US patent for a hemp plant.
Chris Roberts - September 13, 2019Church of England Sees Green, Explores Investing in Medical Cannabis
Britain's largest religious organization announced this week that it will lift a longstanding prohibition on medical cannabis in order to explore investing in the fast-growing industry.
Chris Roberts - June 13, 2019‘Come and Get Us,’ UK Cannabis Growers Tell Police in Protest
As part of a nationwide protest, UK patients who grow their own medical cannabis are identifying themselves to authorities in an effort to force policy reform.
Chris Roberts - May 13, 20194/21 Organizers Want to Reclaim Cannabis From Corporations
A coalition of activists are transforming the day after 4/20 into an advocacy effort aimed at reintroducing social justice into cannabis legalization.
Chris Roberts - April 18, 2019The US Surgeon General Just Tweeted WHAT About Cannabis?
US Surgeon General Jerome Adams recently used his official Twitter account to make a startling claim about cannabis. It wasn't the first time.
Chris Roberts - March 1, 2019Is a Tobacco Giant Trying to Take Over the Vape Pen Market?
In a move that could shake up the vape pen market, the parent company of Philip Morris has quietly patented dozens of devices that could be used to consume cannabis.
Chris Roberts - December 11, 2018UK Cannabis Patient #1: Accessing the Most Expensive Medical Marijuana in the World
Carly Barton, 32, is officially the United Kingdom’s first medical marijuana patient. But access comes at a steep cost—and remains entirely theoretical.
Chris Roberts - December 10, 2018